Hvornår offentliggør Alexion Pharmaceuticals, Inc. en resultatopgørelse?
Alexion Pharmaceuticals, Inc. resultatopgørelse offentliggøres en gang i kvartalet, den seneste årsregnskab for Alexion Pharmaceuticals, Inc. blev offentliggjort den 31/12/2019.
Hvad er fortjenesten fra aktierne i Alexion Pharmaceuticals, Inc.?
Anslået indtjening pr. aktie i Alexion Pharmaceuticals, Inc. var 2.71 $ i den sidste regnskabsrapport.
Hvornår vil Alexion Pharmaceuticals, Inc. offentliggøre næste resultatopgørelse?
Den næste rapport om resultatopgørelsen Alexion Pharmaceuticals, Inc. vil offentliggøres i Marts 2025.
Alexion Pharmaceuticals, Inc. indtjening pr. Aktie - virksomhedens økonomiske karakteristika på størrelsen af dens værdi. Resultat pr. Aktie - beregnet værdi: den samlede fortjeneste for rapporteringsperioden divideres med antallet af eksisterende aktier. Alexion Pharmaceuticals, Inc. indtjening pr. Aktie beregnes for hvert økonomisk interval. Fortjeneste på Alexion Pharmaceuticals, Inc. - samlet overskud for den rapporterede regnskabsperiode.
|
Fortjeneste Alexion Pharmaceuticals, Inc.
Alle Alexion Pharmaceuticals, Inc. overskud er en reference. Det er ikke så vigtigt for private aktionærer. Aktionærer er mere interesseret i indtjening pr. Aktie. Det påvirker primært det modtagne udbytte på aktier. Datoen for resultatopgørelsen for Alexion Pharmaceuticals, Inc. fastlægges ved lov og organisationens regler. Alle datoer for Alexion Pharmaceuticals, Inc. overskudsrapporter vises i vores skema og vores tabel.
|
Kvartalsresultatet Alexion Pharmaceuticals, Inc.
Earnings per share Alexion Pharmaceuticals, Inc. is calculated according to the formula: net income divided by the total number of shares in the company. Earnings per share Alexion Pharmaceuticals, Inc. is an indicator of a certain financial interval. It is easy to guess that the financial period coincides with the publication of financial statements of profit. Alexion Pharmaceuticals, Inc. earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). Quarterly profit Alexion Pharmaceuticals, Inc. is the main type of financial statements among companies.
|
|
ALXN rapport dato
|
Indtjening pr. aktie
Resultat pr. aktie beregnes ved at dividere nettoindkomst (eller overskud) med antallet af aktier i selskabet.
|
Ændring i det sidste år %
|
|
31/12/2019 |
2.71 USD |
+42.97% ↑ |
|
30/09/2019 |
2.79 USD |
+41.96% ↑ |
|
30/06/2019 |
2.64 USD |
+37.33% ↑ |
|
31/03/2019 |
2.39 USD |
+45.91% ↑ |
|
31/12/2018 |
2.14 USD |
+42.66% ↑ |
|
30/09/2018 |
2.02 USD |
+31.89% ↑ |
|
30/06/2018 |
2.07 USD |
+35.54% ↑ |
|
31/03/2018 |
1.68 USD |
+21.71% ↑ |
|
31/12/2017 |
1.48 USD |
+2.37% ↑ |
|
30/09/2017 |
1.44 USD |
+12.54% ↑ |
|
30/06/2017 |
1.56 USD |
+7.08% ↑ |
|
31/03/2017 |
1.38 USD |
+8.69% ↑ |
|
31/12/2016 |
1.26 USD |
+13.07% ↑ |
|
30/09/2016 |
1.23 USD |
+16.35% ↑ |
|
30/06/2016 |
1.13 USD |
-17.819% ↓ |
|
31/03/2016 |
1.11 USD |
-16.747% ↓ |
|
31/12/2015 |
1.13 USD |
-16.776% ↓ |
|
30/09/2015 |
1.16 USD |
-14.74% ↓ |
|
30/06/2015 |
1.44 USD |
+29.8% ↑ |
|
31/03/2015 |
1.28 USD |
+5.32% ↑ |
|
31/12/2014 |
1.3 USD |
+54.25% ↑ |
|
30/09/2014 |
1.27 USD |
+46.44% ↑ |
|
30/06/2014 |
1.12 USD |
+57.24% ↑ |
|
31/03/2014 |
1.53 USD |
+107.88% ↑ |
|
31/12/2013 |
0.87 USD |
+58.15% ↑ |
|
30/09/2013 |
0.83 USD |
+67.32% ↑ |
|
30/06/2013 |
0.73 USD |
+83.15% ↑ |
|
31/03/2013 |
0.65 USD |
+55.76% ↑ |
|
31/12/2012 |
0.6 USD |
+53.38% ↑ |
|
30/09/2012 |
0.6 USD |
+63.34% ↑ |
|
30/06/2012 |
0.47 USD |
+38.85% ↑ |
|
31/03/2012 |
0.45 USD |
+53.33% ↑ |
|
31/12/2011 |
0.41 USD |
+37.93% ↑ |
|
30/09/2011 |
0.37 USD |
+29.6% ↑ |
|
30/06/2011 |
0.29 USD |
+41.39% ↑ |
|
31/03/2011 |
0.3 USD |
+47.35% ↑ |
|
31/12/2010 |
0.26 USD |
+110.57% ↑ |
|
30/09/2010 |
0.25 USD |
+110.11% ↑ |
|
30/06/2010 |
0.2 USD |
+130.17% ↑ |
|
31/03/2010 |
0.19 USD |
+151.6% ↑ |
|
31/12/2009 |
0.12 USD |
+199.19% ↑ |
|
30/09/2009 |
0.19 USD |
+437.06% ↑ |
|
30/06/2009 |
0.13 USD |
-339.625% ↓ |
|
31/03/2009 |
0.13 USD |
-163.86% ↓ |
|
31/12/2008 |
0.085 USD |
-133.027% ↓ |
|
30/09/2008 |
0.12 USD |
-110.888% ↓ |
|
30/06/2008 |
0.015 USD |
-86.749% ↓ |
|
31/03/2008 |
-0.0275 USD |
-59.859% ↓ |
|
31/12/2007 |
-0.0825 USD |
-59.33% ↓ |
|
30/09/2007 |
-0.138 USD |
-33.588% ↓ |
|
30/06/2007 |
-0.188 USD |
-12.984% ↓ |
|
31/03/2007 |
-0.23 USD |
-7.15% ↓ |
|
31/12/2006 |
-0.298 USD |
- |
|
30/09/2006 |
-0.255 USD |
- |
|
30/06/2006 |
-0.265 USD |
- |
|
31/03/2006 |
-0.22 USD |
- |
Alexion Pharmaceuticals, Inc. quarterly earnings per share are the estimated profitability of the company. They have intermediate significance among analysts. But annual earnings per share are of primary importance. Last quarterly profit Alexion Pharmaceuticals, Inc. is now considered to be quarterly profit for the last closed fiscal quarter of this year. Change in profit Alexion Pharmaceuticals, Inc. for the year is a calculated value for additional information that shows the change in percentage of profit with the same interval of the last year. A change in Alexion Pharmaceuticals, Inc. quarterly profit compared to last year may be significant for companies with a seasonal business. But the main indicator of the company's profitability is the annual change in profit.
The dynamics of the company's profit is displayed as a percentage. Overskudshistorikken for Alexion Pharmaceuticals, Inc. for tidligere år fremgår af vores tabel "Kvartalsvis overskud". Alexion Pharmaceuticals, Inc. kvartalsvis indtægtshistorikdatabase er synlig online i det sidste årti. Virksomhedens Alexion Pharmaceuticals, Inc. overskudsdatabase for tidligere år er samlet fra åbne kilder.
|
